Ginkgo Bioworks Holdings (DNA) Cash from Operations Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 25.96% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 9.08% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -12.16% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 92.39% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 32.57% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -9.98% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -129.09% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -119.28% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.98% |
| Mar 31, 2026 | 9.38% |
| Dec 31, 2025 | -12.36% |
| Sep 30, 2025 | 69.46% |
| Jun 30, 2025 | 52.30% |
| Mar 31, 2025 | 42.28% |
| Dec 31, 2024 | 26.62% |
| Sep 30, 2024 | -40.72% |
| Jun 30, 2024 | -14.76% |
| Mar 31, 2024 | 1.46% |
| Dec 31, 2023 | 44.68% |
| Sep 30, 2023 | -159.34% |
| Jun 30, 2023 | 26.03% |
| Mar 31, 2023 | -355.25% |
| Dec 31, 2022 | 36.85% |
| Sep 30, 2022 | -441.76% |
| Jun 30, 2022 | -184.75% |
| Mar 31, 2022 | 58.66% |
| Dec 31, 2021 | -178.98% |